More Drugmakers Pursuing Non-competitive Research Partnerships, Deloitte Says

Drug Industry Daily
A A
Drugmakers are increasingly using joint ventures and research consortia to accelerate early stages of drug development and share the burden of cost, according to Deloitte.

To View This Article:

Login

Subscribe To Drug Industry Daily